Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism

Journal of Nephrology

Volumn 20, Issue 2, 2007, Pages 164-172

  Chudek, Jerzy ^a,b   Nagy, Anetta ^b   Kokot, Franciszek ^a   Podwiński, Antoni ^a   Wiecek, Andrzej ^a   Ritz, Eberhard ^b   Kovacs, Gyula ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Genetic changes; Microsatellite analysis; Primary hyperparathyroidism; Secondary hyperparathyroidism; Serum phospate

Indexed keywords

ALFACALCIDOL; CALCIUM; CALCIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHROMOSOME ABERRATION; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; SECONDARY HYPERPARATHYROIDISM; TUMOR VOLUME; UREMIA;

ADENOMA; ADULT; AGED; ALLELES; CALCIUM; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM, PRIMARY; HYPERPARATHYROIDISM, SECONDARY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PHOSPHATES;

EID: 34447526892     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Bebelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-7.
2. Carlson KM, Dou S, Scavarda N, Toshima K, Jackson CE, Wells SA, Goodfellow PJ, Donis-Keller H. Single missense mutation in the thyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A 1994; 91: 1579-83.
3. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BA. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-60.
4. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002; 32: 676-80.
5. Bai M, Quinn S, Trivedi S, Kifor O, Pearce SH, Pollak M, Kvapcho K, Herbert SC, Brown EM. Expression and characterization of inactivating and activating mutations in the human Ca2+ sensing receptor. J Biol Chem 1996; 271: 19537-45.
6. Farnebo F, Teh BT, Kytölä S, Svensson A, Phelan C, Sandelin K, Thompson NW, Höög A, Weber G, Farnebo L-O, Larsson C. Alteration of MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 1998; 83: 2627-30.
7. Tanaka C, Uchino S, Noguchi S, Nishioka T, Yamasaki H, Hashimoto K, Yoshimoto, K. Biallelic inactivation by somatic mutation of the MEN1 gene in sporadic parathyroid tumors. Cancer Lett 2002; 175: 175-9.
8. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 1996; 56: 599-605.
9. Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RS, Arnold A. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab 1998; 83: 1766-70.
10. Arnold A, Brown MF, Urena P, Gaz R, Sarfati E, Drueke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-53.
11. Chudek J, Ritz E, Kovacs G. Genetic abnormalities in parathyroid nodules of uremic patients. Clin Cancer Res 1998; 4: 211-4.
12. Koshiishi N, Chong JM, Fukasawa T, Ikeno R, Tanaka A, Kanazawa K, Ogura M, Ebuchi M, Takizawa T, Funata N, Fukayama M. Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland. Lab Invest 1999; 79: 1051-8.
13. Nagy A, Chudek J, Kovacs G. Accumulation of allelic changes at chromosome 7p, 18q and 2 in parathyroid lesions of uremic patients. Lab Invest 2001; 81: 527-33.
14. Imanishi Y, Tahara H, Palanisamy N, Spitalny S, Salusky IB, Goodman W, Brandi ML, Drueke TB, Sarfati E, Urena P, Chaganti RS, Arnold A. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. J Am Soc Nephrol 2002; 13: 1490-8.
15. Harach HR, Jasani B. Parathyroid hyperplasia in tertiary hyperparathyroidism: a pathological and immunohistochemical reappraisal. Histopathology 1992; 21: 513-9.
16. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 1996; 56: 599-605.
17. Farnebo F, Kytölä S, The BT, Dwight T, Wong FK, Höög A, Elvius M, Wassif WS, Thompson NW, Farnebo L-O, Sandelin K, Larsson C. Alternative genetic pathways in parathyroid tumorigenesis. J Clin Endocrinol Metab 1999; 84: 3775-80.
18. Afonso S, Santamaria I, Guinsburg ME, Gomez AO, Miranda JL, Jofre R, Menarguez J, Cannata-Andia J, Cigudosa JC. Chromosomal aberrations, the consequence of refractory hyperparathyroidism: its relationship with biochemical parameters. Kidney Int 2003; 63 (Suppl 85): S32-8.
19. Tominaga Y, Hohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Sur 1996; 20: 744-52.
20. Denda M, Finch J, Slatopolsky E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 1996; 38: 596-602.
21. Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats, the effects of calcium phosphate and vitamin D. J Clin Invest 1995; 96: 1786-93.
22. Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats, possible direct role of phosphorus. Nephron 1995; 70: 242-8.
23. wAF1 and transforming growth factor-α mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 2001; 59: 855-65.
24. Xiaoyun W, Xiaobin W, Fouhua Z, Biao L, Tao P. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant 2003; 18 (Suppl 4): 137 [M437].
25. Broadus AE, Magee JS, Mallette LE, Horst RL, Lang R, Jensen PS, Gertner JM, Baron R. A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1983; 56: 953-61.
26. Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H, Iida M. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cell-dependent kinase inhibitors, p21 and p27. Nephrol Dial Transplant 2003; 18 (Suppl 3): iii9-12.
27. Rao SD, Honasoge MD, Divine GW, Phillips ER, Lee MW, Ansari MR, Talpos GB, Parfitt AM. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 2000; 85: 1054-8.